(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202606 | 202506 | % Var | 202606 | 202506 | % Var | 202603 | 202503 | % Var | |
| Sales | 2029.50 | 1825.70 | 11.16 | 2029.50 | 1825.70 | 11.16 | 7383.30 | 7524.10 | -1.87 |
| Other Income | 627.90 | 320.30 | 96.03 | 627.90 | 320.30 | 96.03 | 1953.70 | 1345.90 | 45.16 |
| PBIDT | 1572.00 | 1186.40 | 32.50 | 1572.00 | 1186.40 | 32.50 | 5331.50 | 4665.60 | 14.27 |
| Interest | 0.50 | 0.40 | 25.00 | 0.50 | 0.40 | 25.00 | 2.00 | 1.20 | 66.67 |
| PBDT | 1571.50 | 1186.00 | 32.50 | 1571.50 | 1186.00 | 32.50 | 5329.50 | 4664.40 | 14.26 |
| Depreciation | 65.60 | 61.40 | 6.84 | 65.60 | 61.40 | 6.84 | 254.30 | 247.70 | 2.66 |
| PBT | 1505.90 | 1124.60 | 33.91 | 1505.90 | 1124.60 | 33.91 | 5075.20 | 4416.70 | 14.91 |
| TAX | 302.10 | 265.70 | 13.70 | 302.10 | 265.70 | 13.70 | 1109.40 | 1021.80 | 8.57 |
| Deferred Tax | 14.50 | -3.40 | -526.47 | 14.50 | -3.40 | -526.47 | 14.50 | -7.20 | -301.39 |
| PAT | 1203.80 | 858.90 | 40.16 | 1203.80 | 858.90 | 40.16 | 3965.80 | 3394.90 | 16.82 |
| Equity | 152.00 | 152.00 | 0.00 | 152.00 | 152.00 | 0.00 | 152.00 | 152.00 | 0.00 |
| PBIDTM(%) | 77.46 | 64.98 | 19.20 | 77.46 | 64.98 | 19.20 | 72.21 | 62.01 | 16.45 |
| Company Name | CMP |
|---|---|
| Sun Pharma. Inds. | 1924.90 |
| Dr. Reddys Labs. | 1202.00 |
| Cipla | 1450.00 |
| Lupin | 2235.00 |
| Zydus Lifesciences | 1140.00 |
| View more.. | |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: